BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38548349)

  • 1. Development of a CD163-Targeted PET Radiotracer That Images Resident Macrophages in Atherosclerosis.
    Zhang X; Heo GS; Li A; Lahad D; Detering L; Tao J; Gao X; Zhang X; Luehmann H; Sultan D; Lou L; Venkatesan R; Li R; Zheng J; Amrute J; Lin CY; Kopecky BJ; Gropler RJ; Bredemeyer A; Lavine K; Liu Y
    J Nucl Med; 2024 May; 65(5):775-780. PubMed ID: 38548349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 64Cu-DOTATATE PET/MRI for Detection of Activated Macrophages in Carotid Atherosclerotic Plaques: Studies in Patients Undergoing Endarterectomy.
    Pedersen SF; Sandholt BV; Keller SH; Hansen AE; Clemmensen AE; Sillesen H; Højgaard L; Ripa RS; Kjær A
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1696-703. PubMed ID: 25977567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD163+ macrophages are associated with a vulnerable plaque phenotype in human carotid plaques.
    Bengtsson E; Hultman K; Edsfeldt A; Persson A; Nitulescu M; Nilsson J; Gonçalves I; Björkbacka H
    Sci Rep; 2020 Sep; 10(1):14362. PubMed ID: 32873809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT and MR imaging biomarker of lipid-rich plaques using [64Cu]-labeled scavenger receptor (CD68-Fc).
    Bigalke B; Phinikaridou A; Andia ME; Cooper MS; Schuster A; Wurster T; Onthank D; Münch G; Blower P; Gawaz M; Nagel E; Botnar RM
    Int J Cardiol; 2014 Nov; 177(1):287-91. PubMed ID: 25499394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI.
    Tarin C; Carril M; Martin-Ventura JL; Markuerkiaga I; Padro D; Llamas-Granda P; Moreno JA; García I; Genicio N; Plaza-Garcia S; Blanco-Colio LM; Penades S; Egido J
    Sci Rep; 2015 Nov; 5():17135. PubMed ID: 26616677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles.
    Luehmann HP; Detering L; Fors BP; Pressly ED; Woodard PK; Randolph GJ; Gropler RJ; Hawker CJ; Liu Y
    J Nucl Med; 2016 Jul; 57(7):1124-9. PubMed ID: 26795285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis.
    Guo L; Akahori H; Harari E; Smith SL; Polavarapu R; Karmali V; Otsuka F; Gannon RL; Braumann RE; Dickinson MH; Gupta A; Jenkins AL; Lipinski MJ; Kim J; Chhour P; de Vries PS; Jinnouchi H; Kutys R; Mori H; Kutyna MD; Torii S; Sakamoto A; Choi CU; Cheng Q; Grove ML; Sawan MA; Zhang Y; Cao Y; Kolodgie FD; Cormode DP; Arking DE; Boerwinkle E; Morrison AC; Erdmann J; Sotoodehnia N; Virmani R; Finn AV
    J Clin Invest; 2018 Mar; 128(3):1106-1124. PubMed ID: 29457790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CC Chemokine Receptor 5 Targeted Nanoparticles Imaging the Progression and Regression of Atherosclerosis Using Positron Emission Tomography/Computed Tomography.
    Detering L; Abdilla A; Luehmann HP; Williams JW; Huang LH; Sultan D; Elvington A; Heo GS; Woodard PK; Gropler RJ; Randolph GJ; Hawker CJ; Liu Y
    Mol Pharm; 2021 Mar; 18(3):1386-1396. PubMed ID: 33591187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a CCR2 targeted
    Zhang X; Qiu L; Sultan DH; Luehmann HP; Yu Y; Zhang X; Heo GS; Li A; Lahad D; Rho S; Tu Z; Liu Y
    Nucl Med Biol; 2024; 130-131():108893. PubMed ID: 38422918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting CAIX with [
    Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z
    Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages.
    Gleissner CA; Shaked I; Erbel C; Böckler D; Katus HA; Ley K
    Circ Res; 2010 Jan; 106(1):203-11. PubMed ID: 19910578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Modular Construction of a Polymeric Nanoparticle for Targeted Atherosclerosis Positron Emission Tomography Imaging: A Story of 25% (64)Cu-CANF-Comb.
    Woodard PK; Liu Y; Pressly ED; Luehmann HP; Detering L; Sultan DE; Laforest R; McGrath AJ; Gropler RJ; Hawker CJ
    Pharm Res; 2016 Oct; 33(10):2400-10. PubMed ID: 27286872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron Emission Tomography Imaging of Macrophages in Atherosclerosis with
    Hellberg S; Liljenbäck H; Eskola O; Morisson-Iveson V; Morrison M; Trigg W; Saukko P; Ylä-Herttuala S; Knuuti J; Saraste A; Roivainen A
    Contrast Media Mol Imaging; 2018; 2018():9186902. PubMed ID: 29950954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 64Cu-Labeled Divalent Cystine Knot Peptide for Imaging Carotid Atherosclerotic Plaques.
    Jiang L; Tu Y; Kimura RH; Habte F; Chen H; Cheng K; Shi H; Gambhir SS; Cheng Z
    J Nucl Med; 2015 Jun; 56(6):939-44. PubMed ID: 25908832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [
    Meletta R; Slavik R; Mu L; Rancic Z; Borel N; Schibli R; Ametamey SM; Krämer SD; Müller Herde A
    Nucl Med Biol; 2017 Apr; 47():31-43. PubMed ID: 28104528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using (
    Varasteh Z; De Rose F; Mohanta S; Li Y; Zhang X; Miritsch B; Scafetta G; Yin C; Sager HB; Glasl S; Gorpas D; Habenicht AJR; Ntziachristos V; Weber WA; Bartolazzi A; Schwaiger M; D'Alessandria C
    Theranostics; 2021; 11(4):1864-1876. PubMed ID: 33408786
    [No Abstract]   [Full Text] [Related]  

  • 17. PET imaging of chemokine receptors in vascular injury-accelerated atherosclerosis.
    Liu Y; Pierce R; Luehmann HP; Sharp TL; Welch MJ
    J Nucl Med; 2013 Jul; 54(7):1135-41. PubMed ID: 23658218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT imaging of chemokine receptor CCR5 in vascular injury model using targeted nanoparticle.
    Luehmann HP; Pressly ED; Detering L; Wang C; Pierce R; Woodard PK; Gropler RJ; Hawker CJ; Liu Y
    J Nucl Med; 2014 Apr; 55(4):629-34. PubMed ID: 24591489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
    Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis.
    Moreno JA; Muñoz-García B; Martín-Ventura JL; Madrigal-Matute J; Orbe J; Páramo JA; Ortega L; Egido J; Blanco-Colio LM
    Atherosclerosis; 2009 Nov; 207(1):103-10. PubMed ID: 19473660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.